Teleflex, Inc. (TFX)
140.95
+0.47
(+0.33%)
USD |
NYSE |
Sep 02, 16:00
140.95
0.00 (0.00%)
After-Hours: 20:00
Teleflex Research and Development Expense (TTM) : 195.47M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 195.47M |
| March 31, 2026 | 176.84M |
| December 31, 2025 | 157.75M |
| September 30, 2025 | 138.21M |
| June 30, 2025 | 119.71M |
| March 31, 2025 | 134.32M |
| December 31, 2024 | 146.32M |
| September 30, 2024 | 152.98M |
| June 30, 2024 | 151.83M |
| March 31, 2024 | 150.18M |
| December 31, 2023 | 154.35M |
| September 30, 2023 | 161.25M |
| June 30, 2023 | 161.44M |
| March 31, 2023 | 158.93M |
| December 31, 2022 | 153.82M |
| September 30, 2022 | 146.86M |
| June 30, 2022 | 140.90M |
| March 31, 2022 | 137.25M |
| December 31, 2021 | 130.84M |
| September 30, 2021 | 128.82M |
| June 30, 2021 | 126.22M |
| March 31, 2021 | 122.30M |
| December 31, 2020 | 119.75M |
| September 30, 2020 | 117.11M |
| June 30, 2020 | 115.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 114.10M |
| December 31, 2019 | 113.86M |
| September 30, 2019 | 110.53M |
| June 30, 2019 | 108.91M |
| March 31, 2019 | 107.33M |
| December 31, 2018 | 106.21M |
| September 30, 2018 | 103.88M |
| June 30, 2018 | 98.71M |
| March 31, 2018 | 92.97M |
| December 31, 2017 | 84.77M |
| September 30, 2017 | 74.99M |
| June 30, 2017 | 68.86M |
| March 31, 2017 | 64.05M |
| December 31, 2016 | 58.58M |
| September 30, 2016 | 56.11M |
| June 30, 2016 | 53.62M |
| March 31, 2016 | 51.59M |
| December 31, 2015 | 52.12M |
| September 30, 2015 | 56.14M |
| June 30, 2015 | 58.44M |
| March 31, 2015 | 59.86M |
| December 31, 2014 | 61.04M |
| September 30, 2014 | 61.68M |
| June 30, 2014 | 62.45M |
| March 31, 2014 | 64.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 147.06M |
| Boston Scientific Corp. | 2.153B |
| Penumbra, Inc. | 75.84M |
| Alphatec Holdings, Inc. | 76.69M |
| Becton, Dickinson & Co. | 1.135B |